Sakari Hietanen

- Docent,
Faculty of Medicine (University of Turku)
- ,
Obstetrics and Gynaecology (Department of Clinical Medicine)

sakari.hietanen@utu.fi

Publications

3 of 8

Real-life treatment patterns and time to next treatment among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland Study (2024)
- Acta Oncologica
Lahelma, Mari; Rauhamaa, Heini; Isomeri, Outi; Idänpään-Heikkilä, Juhana; Käkelä, Sari; Roebuck, Nichola; Mascialino, Barbara; Hietanen, Sakari; Loukovaara, Mikko; Auranen, Annika
(A1 Refereed original research article in a scientific journal)
Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinomaComorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus (2023)
- Biomedicine and PharmacotherapyJournal of Lower Genital Tract Disease
Nguyen Mai TN, Rajavuori Anna, Huhtinen Kaisa, Hietanen Sakari, Hynninen Johanna, Oikkonen Jaana, Hautaniemi Sampsa
(A1 Refereed original research article in a scientific journal)
(2023)
Söderlund Jenni M, Hieta Niina K, Kurki Samu H, Orte Katri J, Polo-Kantola Päivi, Hietanen Sakari H, Haataja Marjut AM
(A1 Refereed original research article in a scientific journal)
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial (2023)
- European Journal of Cancer
Sabatier Renaud, Rousseau Frédérique, Joly Florence, Cropet Claire, Montégut Coline, Frindte Johanna, Cinieri Saverio, Guerra Alía Eva M, Polterauer Stephan, Yoshida Hiroyuki, Vergote Ignace, Colombo Nicoletta, Hietanen Sakari, Largillier Rémi, Canzler Ulrich, Gratet Alain, Marmé Frederick, Favier Laure, Pujade-Lauraine Eric, Ray-Coquard Isabelle
(A1 Refereed original research article in a scientific journal)
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinomaEvolutionary study identifies poor prognosis HGSC patients and reveals clinically relevant targets at diagnosis and relapse (2023)
- Cancer Cell
Lahtinen Alexandra, Lavikka Kari, Virtanen Anni, Li Yilin, Jamalzadeh Sanaz, Skorda Aikaterini, Lauridsen Anna Rössberg, Zhang Kaiynag, Marchi Giovanni, Isoviita Veli-Matti, Ariotta Valeria, Lehtonen Oskari, Muranen Taru A., Huhtinen Kaisa, Carpén Olli, Hietanen Sakari, Senkowski Wojciech, Kallunki Tuula, Häkkinen Aantti, Hynninen Johanna, Oikkonen Jaana, Hautaniemi SampsaA1 Refereed original research article in a scientific journal
2023
- International Journal of Gynecological Cancer
Oikkonen, Jaana; Lahtinen, Alexandra; Lavikka, Kari; Virtanen, Anni; Li, Yilin; Jamalzadeh, Sanaz; Skorda, Aikaterini; Lauridsen, Anna Rossberg; Zhang, Kaiyang; Marchi, Giovanni; Nguyen, Mai T. N.; Rajavuori, Anna; Muranen, Taru A.; Huhtinen, Kaisa; Hietanen, Sakari; Senkowski, Wojciech; Kallunki, Tuula; Hakkinen, Antti; Hynninen, Johanna; Hautaniemi, Sampsa
(Other publication)
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes (2023)
- Clinical Cancer ResearchJCO Precision Oncology
Pikkusaari Sanna, Tumiati Manuela, Virtanen Anni, Oikkonen Jaana, Li Yilin, Perez-Villatoro Fernando, Muranen Taru, Salko Matilda, Huhtinen Kaisa, Kanerva Anna, Koskela Heidi, Tapper Johanna, Koivisto-Korander Riitta, Joutsiniemi Titta, Haltia Ulla-Maija, Lassus Heini, Hautaniemi Sampsa, Färkkilä Anniina, Hynninen Johanna, Hietanen Sakari, Carpen Olli, Kauppi Liisa
(A1 Refereed original research article in a scientific journal)
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial (2023)
Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, du Bois A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Lorente CM, Berton D, Runnebaum IB, Ray-Coquard I
(A1 Refereed original research article in a scientific journal)
Multi-omics characterization of chemo-refractory high-grade serous cancer (2023)
- International Journal of Gynecological Cancer
Muranen, Taru A.; Afenteva, Daria; Rajavuori, Anna; Jamalzadeh, Sanaz; Zhang, Kaiyang; Ariotta, Valeria; Isoviita, Veli-Matti; Lahtinen, Alexandra; Lavikka, Kari; Lehtonen, Oskari; Li, Yilin; Marchi, Giovanni; Oikkonen, Jaana; Salloum, Shams; Huhtinen, Kaisa; Hietanen, Sakari; Virtanen, Anni; Hynninen, Johanna; Hautaniemi, Sampsa
(Other publication)
Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma (2023)
- JCO Precision Oncology
Christinat Yann, Ho Liza, Clément Sophie, Genestie Catherine, Sehouli Jalid, Cinieri Saverio, Gonzalez Martin Antonio, Denison Ursula, Fujiwara Keiichi, Vergote Ignace, Tognon Germana, Hietanen Sakari, Ray-Coquard Isabelle, Pujade-Lauraine Eric, McKee Thomas A
(A1 Refereed original research article in a scientific journal)